New treatments of pancreatic neuroendocrine tumors: why using them? How to use them?

Target Oncol. 2012 Jun;7(2):91-2. doi: 10.1007/s11523-012-0222-0. Epub 2012 Jun 5.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Everolimus
  • Humans
  • Indoles / therapeutic use
  • Neuroendocrine Tumors / blood supply
  • Neuroendocrine Tumors / drug therapy*
  • Pancreatic Neoplasms / blood supply
  • Pancreatic Neoplasms / drug therapy*
  • Pyrroles / therapeutic use
  • Randomized Controlled Trials as Topic
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use
  • Sunitinib

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Everolimus
  • Sunitinib
  • Sirolimus